Frequently Asked Questions Laboratory Use What is Retatrutide GLP3-R
Mounjaro (tirzepatide) received TGA approval in 2023
Serious side effects are less common but may include pancreatitis, gallbladder problems, kidney problems related to dehydration, severe stomach problems, allergic reactions, low blood sugar in people with type 2 diabetes, vision changes, and a possible risk of thyroid tumors
Considering the pleiotropic beneficial actions, excellent safety and tolerability profile, ALCAR has been employed in clinical settings related to neurological disorders [26, 28, 29]
Another two-year study of 500 type 2 diabetes patients showed 15% experienced decreased B12 levels, with 5% developing outright deficiency